Category Archives: Press Releases

Precipio Takes Major Steps Toward a Clean Balance Sheet

Less than $80,000 of long-term debt, and 10,000 vendor warrants remain outstanding NEW HAVEN, CT, [...]

Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

Joint study conducted with Memorial Sloan Kettering Cancer Center demonstrates clear, positive impacts on patient [...]

Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

NEW HAVEN, CT, (December 4, 2025) – Precipio, Inc. reports that the Company recently identified a [...]

Precipio Announces its Q3-2025 Financial Results

Over $450,000 Adjusted EBITDA and $275,000 positive operating cash flow for the quarter NEW HAVEN, [...]

Precipio Announces Q3-2025 Shareholder Update Call

Conference Call to be held on November 17th, 2025 at 5:00 PM EST NEW HAVEN, [...]

Precipio Terminates Its ATM

Management Decision Further Reinforces Commitment to Responsible Capital Management NEW HAVEN, CT, (September 2nd, 2025) – [...]

Precipio Announces its Q2-2025 Financial Results

Conference call to follow tomorrow, August 14 at 5 PM EST  NEW HAVEN, CT, (August [...]

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

NEW HAVEN, CT, (July 11th, 2025) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:  PRPO) has entered into [...]

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

NEW HAVEN, CT, (June 16th, 2025) – Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting [...]

Precipio Announces its Q1-2025 Financial Results

Conference call to follow tomorrow, May 15 at 5 PM EST NEW HAVEN, CT, (May [...]